These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 36057193)
1. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review. Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739 [TBL] [Abstract][Full Text] [Related]
3. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai). Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094 [TBL] [Abstract][Full Text] [Related]
4. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review. Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083 [TBL] [Abstract][Full Text] [Related]
5. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329 [TBL] [Abstract][Full Text] [Related]
6. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study. Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154 [TBL] [Abstract][Full Text] [Related]
7. The role of biologics in chronic rhinosinusitis: a systematic review. Iqbal IZ; Kao SS; Ooi EH Int Forum Allergy Rhinol; 2020 Feb; 10(2):165-174. PubMed ID: 31869863 [TBL] [Abstract][Full Text] [Related]
8. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417 [TBL] [Abstract][Full Text] [Related]
9. Biologics in Chronic Rhinosinusitis: Current and Emerging. Boyd JT; Khanwalkar AR Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716 [TBL] [Abstract][Full Text] [Related]
10. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893 [TBL] [Abstract][Full Text] [Related]
11. The Role of Biologics in the Treatment of Nasal Polyps. Franzese CB Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452 [TBL] [Abstract][Full Text] [Related]
12. Real-World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps. Dorling M; Hernaiz-Leonardo JC; Pascual A; Janjua A; Thamboo A; Javer A Laryngoscope; 2024 Jul; 134(7):3054-3059. PubMed ID: 38314858 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428 [TBL] [Abstract][Full Text] [Related]
14. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Patel GB; Peters AT Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132 [TBL] [Abstract][Full Text] [Related]
15. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy. Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD. Brkic FF; Liu DT; Klimbacher R; Campion NJ; Bartosik TJ; Vyskocil E; Stanek V; Tu A; Arnoldner T; Bangert C; Gangl K; Eckl-Dorna J; Schneider S Rhinology; 2023 Aug; 61(4):320-327. PubMed ID: 37515811 [TBL] [Abstract][Full Text] [Related]
17. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?]. Clottu A; Reinhard A; Comte D Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824 [TBL] [Abstract][Full Text] [Related]
18. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis. Geng B; Dilley M; Anterasian C Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505 [TBL] [Abstract][Full Text] [Related]
19. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP). Hardison SA; Senior BA J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322 [TBL] [Abstract][Full Text] [Related]
20. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review. Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]